Author

Keith Potent

Observed name: Potent, Keith

Observed institutions: Griffith University, The University of Queensland, Townsville Hospital, Fremantle Hospital

ORCID: 0000-0003-0465-141X

Observed ORCID: 0000-0003-0465-141X

OpenAlex ID: A5035457318

Global Barriers to Otolaryngology Care

2025 · Rolvix H. Patterson, Ali Haider Bangash, et al. · JAMA Otolaryngology–Head & Neck Surgery · 8

The future of phage clinical trials in Australia

2019 · Keith Potent · Microbiology Australia · 4

Testicular torsion in a 65‐year‐old male identified using Doppler ultrasound

2014 · Keith Potent, Isaac Thyer · ANZ Journal of Surgery · 2

Does a Polyherbal Medicine Enhance Cognition in Healthy Older Adults? An Exploratory Open-Label Study

2024 · Evelin Tiralongo, Vanessa Vigar, et al. · Journal of Integrative and Complementary Medicine · 1

Review of electronic discharge summaries from the general medicine, general surgery and mental health streams at a tertiary hospital: retrospective analysis of timeliness, brevity and completeness

2020 · Keith Potent, Benjamin Levy, et al. · Australian Health Review · 1

Endoscopic Management of Idiopathic Spontaneous Epistaxis in Adults

2026 · Potent, Keith, Smith, Edward, et al. · Open University of Cape Town (University of Cape Town)

Audit of electronic discharge summaries from 3 different tertiary hospital departments: A retrospective analysis of timeliness and quality

2018 · Keith Potent · Health Care Current Reviews

Synthetic bacteriophages as nanoparticles for intravenous administration of targeted gene therapy for cancer

2018 · Keith Potent, Sinclair · Toxicology Open Access

First in human report of intravenous infusion of Metavec (synthetic bacteriophage delivering genetic cargo) in a patient with metastatic ovarian cancer

2018 · Keith Potent, Armand Sinclair · Journal of Cancer Science & Therapy

Works count: 9

Citation count: 16

H-index: 2

I10-index: